- Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial PatientsThe Wall Street Journal
- Medicare will cover Biogen’s $28K Alzheimer’s drug, only in trialsCNBC Television
- Medicare Part B Premium Hike Could Be Reduced as Government Reassesses Alzheimer’s DrugGOBankingRates
- Biogen’s Alzheimer’s Drug Coverage Limited by U.S.Bloomberg Markets and Finance
- Medicare Proposes to Sharply Limit Coverage of the Alzheimer’s Drug AduhelmThe New York Times